Prochlorperazine Suppository
Product Images NDC 0713-0135

2 FDA label images from Cosette Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Prochlorperazine (NDC 0713-0135). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cosette Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Prochlorperazine (Prochlorperazineformula)

Prochlorperazine (Prochlorperazineformula)
Chemical structure diagram of Prochlorperazine, showing its molecular formula (C20H24ClN3S) and molecular weight (373.94). The structure includes aromatic rings and various functional groups.*
FDA Label Image

Prochl-2.jpg (Prochl 2)

Prochl-2.jpg (Prochl 2)
Packaging label for Prochlorperazine 25 mg suppositories USP by Cosette Pharmaceuticals, Inc. The label shows 12 adult suppositories intended for rectal administration, marked Rx only. The design includes the product name, strength, dosage form, and manufacturer information, along with storage and usage directions. The NDC is 0713-0135-12.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.